Skip to main content
The BMJ logoLink to The BMJ
letter
. 1996 Dec 14;313(7071):1550–1551. doi: 10.1136/bmj.313.7071.1550a

Relation between treatment benefit and underlying risk in meta-analysis. Standard of "label invariance" should not be abandoned.

S Senn
PMCID: PMC2353080  PMID: 8978249

Full text

PDF

Page 1550

1550

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Senn S. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Stat Med. 1994 Feb 15;13(3):293–296. doi: 10.1002/sim.4780130310. [DOI] [PubMed] [Google Scholar]
  2. Sharp S. J., Thompson S. G., Altman D. G. The relation between treatment benefit and underlying risk in meta-analysis. BMJ. 1996 Sep 21;313(7059):735–738. doi: 10.1136/bmj.313.7059.735. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES